COLLEGIUM PHARMACEUTICAL INC (COLL) — insider trading
Health Care · NASDAQ
COLLEGIUM PHARMACEUTICAL INC (COLL) has 17 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 17 (latest 2026-06-08).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-08 | SANTINI GINO | Director | Option exercise / conversion (derivative) | 8,700 | $0.00 | $0 | Form 4 |
| 2026-06-08 | SANTINI GINO | Director | Option exercise / conversion | 8,700 | $16.49 | $143.5K | Form 4 |
| 2026-05-18 | Freund John Gordon | Director | Open-market sale | 20 | $34.05 | $681 | Form 4 |
| 2026-05-15 | Freund John Gordon | Director | Option exercise / conversion (derivative) | 8,700 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Freund John Gordon | Director | Open-market sale | 4,127 | $34.54 | $142.5K | Form 4 |
| 2026-05-15 | Freund John Gordon | Director | Option exercise / conversion | 8,700 | $16.49 | $143.5K | Form 4 |
| 2026-05-14 | SANTINI GINO | Director | Grant / award / vesting | 8,741 | $0.00 | $0 | Form 4 |
| 2026-05-14 | Balice-Gordon Rita J. | Director | Grant / award / vesting | 8,741 | $0.00 | $0 | Form 4 |
| 2026-05-14 | BOHLIN GAREN G | Director | Grant / award / vesting | 8,741 | $0.00 | $0 | Form 4 |
| 2026-05-14 | Glancy Donovan Michael | Director | Grant / award / vesting | 17,482 | $0.00 | $0 | Form 4 |
| 2026-05-14 | Freund John Gordon | Director | Grant / award / vesting | 8,741 | $0.00 | $0 | Form 4 |
| 2026-05-14 | Paya Carlos V | Director | Grant / award / vesting | 8,741 | $0.00 | $0 | Form 4 |
| 2026-05-14 | Lurker Nancy | Director | Grant / award / vesting | 8,741 | $0.00 | $0 | Form 4 |
| 2026-05-13 | Lurker Nancy | Director | Open-market sale | 4,500 | $35.97 | $161.9K | Form 4 |
| 2026-05-11 | BOHLIN GAREN G | Director | Option exercise / conversion (derivative) | 8,700 | $0.00 | $0 | Form 4 |
| 2026-05-11 | BOHLIN GAREN G | Director | Open-market sale | 8,700 | $37.18 | $323.5K | Form 4 |
| 2026-05-11 | BOHLIN GAREN G | Director | Option exercise / conversion | 8,700 | $16.49 | $143.5K | Form 4 |
Ask the chat about COLL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: COLLEGIUM PHARMACEUTICAL INC (COLL).
Last updated 2026-06-08 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.